CBD researchers can breathe a little easier now that the DEA has streamlined the CBD research process for ongoing scientific studies. This post from Forbes highlights the impact of this decision on research companies. Christmas came early for cannabis research scientists. The U.S. Drug Enforcement Agency (DEA) decided to ease some of the regulatory requirements that had been ... Continue Reading
FDA
Legalization Advocates Up in Arms Against DEA Chief for His ‘Joke’
Acting DEA chief Chuck Rosenberg’s calling medical marijuana a "joke" didn’t sit well with legalization advocates. This article from The Huffington Post highlights a petition, with thousands demanding his firing, gaining momentum. "President Obama should fire Chuck Rosenberg and appoint a new DEA administrator who will respect science, medicine, patients and voters." A ... Continue Reading
Faster Approval Process for Medical Marijuana Research Takes Effect
In this post from Medical Jane, Arielle Gerard encapsulates the removal of the need for Public Health Service (PHS) approval of medical marijuana research proposals and what it means to us. What Happened? On June 22, 2015, the Obama Administration removed the need for cannabis research proposal review by the Public Health Service (PHS), which will make it easier and faster ... Continue Reading